Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
about
Ring finger protein ZIN interacts with human immunodeficiency virus type 1 VifAn endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsProduction of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cellsFeline immunodeficiency virus Vif localizes to the nucleusImplication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.APOBEC3G inhibits elongation of HIV-1 reverse transcripts.Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcriptionCellular and viral specificities of human immunodeficiency virus type 1 vif protein.Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection.Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes.A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcriptionThe human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexesvif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.Role of Vif in human immunodeficiency virus type 1 reverse transcriptionHIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cellsVif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.Compartmentalization of the gut viral reservoir in HIV-1 infected patients.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinThe DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.Advances in the structural understanding of Vif proteinsAPOBEC proteins and intrinsic resistance to HIV-1 infectionAPOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells.
P2860
Q24304030-7BA3E068-F4C7-46BE-A84C-BD62A4E064D5Q24523705-E2DC2291-D43B-423C-953F-6B136601E63FQ24619114-333E596B-F063-4DA6-8D5C-D54E9D8729BBQ24678970-30ADA975-156F-4946-9C80-0E8759D8CC55Q24796626-627909F5-2112-4BC0-A4B6-29064E9BD004Q27469637-89F14B8F-6130-4DCC-A027-FEDFB2974F5DQ30860339-DE78BD14-69E1-422B-A21E-D4A13B3D5EF0Q31011512-1586395A-183B-4AFB-AD6F-1685A3CB12D7Q33389841-C8B888A9-5AC2-4E06-BB2A-49650A94C8C8Q33604247-0583554E-643F-4D9F-A30B-CD23DE8617B6Q33806688-D5195930-575B-463E-9803-0F2DA294BB71Q33815187-F7EA6B0C-0C93-4F29-952D-764A99C9BB54Q33839136-878C0941-B280-4EB0-95A4-D087B0D64D33Q33841004-4DD609CB-D067-444C-A8A1-9EE41344CA9CQ33841920-223C8014-9DD7-4CD4-8DEF-FA77FFAE7A0CQ33852465-13C626EB-143F-4CDD-992B-5D8D20B54FDAQ34062105-CA1C8739-2482-41DA-A15E-80B7A77043D4Q34312616-7EFFB95B-FB9C-4271-B000-6A6D42586F16Q34345408-AAFF9CC5-09DB-4928-9435-F7774F53785DQ34465108-49BC62FD-5527-4055-AA1A-E446A57BEE6DQ35851202-DC7197C6-0BF3-4B33-8089-055F8D726AEFQ35851966-5F85A1B0-F023-47D4-B0E3-440785910BB3Q35856279-335346D3-2013-49B6-AA45-1ED67D69903FQ35861719-B66F96EA-BD6F-41FD-8253-770C31BD4A7CQ35862080-4B9874FB-4798-4B5E-BC86-61EC98844817Q35866134-05820A29-006F-48E5-A6FC-A877CA97AE4EQ35866177-D1F3E152-AE94-441C-B139-966489DAF682Q35873067-6C9C19F5-8AB9-47B9-96F3-F7D96EC01F87Q35873743-686397D6-5411-4608-A5ED-003E1971D253Q35874198-C1EFFF07-332A-427C-9D62-858C52FA2B0FQ35888172-738BCAC8-C700-486D-B1AD-E4DD538A8311Q35990905-3F16F578-23C0-46FE-B3B0-5E3E2D816B27Q36099054-C99C1CEC-92F0-4387-9852-4C956A691A4BQ36412750-602AB248-9626-4695-B893-0AAA7DBF3051Q36432758-978A3101-5619-45CB-B030-4238D155AF0BQ36484144-9B1C7248-EB18-47EC-A97B-E92F3D0FD532Q36548864-7646B161-54C4-48F4-A225-99DEB35E1F06Q37108363-CAC93283-9BEB-4258-A4E3-7B0E610D06E7Q37140468-D87B5C38-DB53-4D83-893F-1FAF6C1260D8Q37186249-1061A37E-B594-47EB-9C2B-69776D43428B
P2860
Peripheral blood mononuclear cells produce normal amounts of defective Vif- human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Peripheral blood mononuclear c ...... e preretrotranscription steps.
@en
Peripheral blood mononuclear c ...... e preretrotranscription steps.
@nl
type
label
Peripheral blood mononuclear c ...... e preretrotranscription steps.
@en
Peripheral blood mononuclear c ...... e preretrotranscription steps.
@nl
prefLabel
Peripheral blood mononuclear c ...... e preretrotranscription steps.
@en
Peripheral blood mononuclear c ...... e preretrotranscription steps.
@nl
P2093
P2860
P1433
P1476
Peripheral blood mononuclear c ...... he preretrotranscription steps
@en
P2093
Courcoul M
Patience C
P2860
P304
P407
P577
1995-04-01T00:00:00Z